首页> 外文OA文献 >Posttransplant peripheral blood donor–specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients

【2h】

Posttransplant peripheral blood donor–specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients

机译：后移植外周血供体特异性干扰素-γ酶联免疫点测定分化了肾移植受者中亚临床排斥和de Novo供体特异性血管杀虫剂的风险

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Elena Crespo; Paolo Cravedi; Jaume Martorell; Sergi Luque; Edoardo Melilli; Josep M. Cruzado; Marta Jarque; Maria Meneghini; Anna Manonelles; Chiara Donadei; Núria Lloberas; Montse Gomà; Josep M. Grinyó; Peter Heeger; Oriol Bestard;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection. [J] . F Ginevri, A Nocera, P Comoli, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons . 2012,第12期

机译：从头移植后的供体特异性hla抗体可识别出有小儿肾脏受体的抗体介导的晚期排斥反应风险的患儿。
2. Posttransplant De Novo Donor-Specific HLA Antibodies Identify Pediatric Kidney Recipients at Risk for Late Antibody-Mediated Rejection [J] . F. Ginevri, A. Nocera, P. Comoli, American Journal of Transplantation . 2012,第12期

机译：移植后从新供体特异性HLA抗体可确定小儿肾脏接受者处于后期抗体介导拒绝的风险中
3. Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection. [J] . F Ginevri, A Nocera, P Comoli, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons . 2012,第12期

机译：Postransplant de Novo供体特异性HLA抗体识别口科基肾受体，患有晚期抗体介导的排斥反应。
4. TREATMENT OF REFRACTORY ANTIBODY MEDIATED REJECTION WITH BORTEZOMIB IN TWO TRANSPLANT RECIPIENTS: THE IMPACT ON DONOR-SPECIFIC ANTI-HLA ANTIBODIES [C] . John Lunz, Judy Howe, Lawrence Jelinek, Clinical Histocompatibility Workshop. . 2010

机译：治疗难治性抗体在两个移植受者中用硼替佐米介导的抑制剂：对供体特异性抗HLA抗体的影响
5. Eplet Mismatches and De Novo Donor-Specific Antibody Development in Pediatric Kidney Transplant Recipients [D] . Blanchette, Eliza 2019

机译：小儿肾移植受者的EPLET不匹配和De Novo供体特异性抗体发育
6. Post-transplant peripheral blood donor-specific IFN-γ ELISPOT assays differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients [O] . Elena Crespo, Paolo Cravedi, Jaume Martorell, -1

机译：移植后外周血供体特异性IFN-γELISPOT分析可区分肾移植受者亚临床排斥和从头供体特异性同种抗体的风险
7. Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection. [O] . Ginevri F, Nocera A, Comoli P, 2012

机译：移植后的新供体特异性hla抗体可识别出有小儿肾脏受体的抗体介导的晚期排斥反应风险的患儿。

Posttransplant peripheral blood donor–specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients

著录项

相似文献

相关主题

期刊订阅